Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group

Item

http://www.wikidata.org/entity/Q37427903

Q37427903

about

Down syndrome and leukemia: insights into leukemogenesis and translational targets Prognosis and management of acute myeloid leukemia in patients with Down syndrome Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update Current Management of Childhood Acute Myeloid Leukemia.Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder.Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.Advances in paediatric cancer treatment Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome.Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study.Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.Transient myeloproliferative disorder in neonates without Down syndrome: case report and review.Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia.Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan.Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.Down syndrome associated childhood myeloid leukemia with yet unreported acquired chromosomal abnormalities and a new potential adverse marker: dup(1)(q25q44).Acute myeloid leukemia in children: Current status and future directions.

P2860

Q26770335-8DDC5659-AD69-4657-837B-24AA70E7C144 Q27016577-C23058EF-64A3-44FA-9B56-F84D6867BA09 Q28079980-BCECF21C-DE49-4FE0-A791-907090904AD8 Q30244036-4D2F1795-DA09-4882-972C-A4BD15E14B17 Q34299039-3D590A1A-F609-4BAC-B1E0-335896030E2B Q35888110-03A60F75-B193-4004-AE5E-0FBFF101E864 Q36053792-154D3FD6-5A0C-4A26-B344-73E5741A7A0C Q36508630-DD214833-26B0-4AB2-A9EE-363C14B789F7 Q37000896-E3816485-AFB1-4D38-BB09-B7EEB4ACF189 Q37215179-454E1428-CF6F-48BD-8EFB-4281FDFE846C Q37552027-25F10472-BDBC-4FE3-8523-6C7A1EA413D9 Q38068816-079A8188-C35A-498C-A35D-0CD6DF29B96A Q38196743-2104591E-13E0-4BE3-824A-1A4B791E16E9 Q38213905-2DFE0510-7D88-42D6-9B18-A056C228F7ED Q38733360-7BECDE17-0254-4503-9605-9885DE59A1B9 Q39107353-73EFF339-969D-4439-B897-212BA8525DD1 Q41203406-1A1A0D05-00D8-4EC0-8387-6E0AF6140C66 Q41724174-F0C4D553-DE6D-4A58-9D7A-A7574516B4B4 Q46145690-6D089C7E-B2A5-449C-952D-828DD2000A7B Q52643638-368D1C58-BA22-4335-81F4-2BB08976C965 Q52897332-3CB63F9A-9909-4FE7-9A3E-7691590E0CA2

P2860

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group

Item

http://www.wikidata.org/entity/Q37427903

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 March 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Favorable survival maintained ...... the Children's Oncology Group

@en

Favorable survival maintained ...... the Children's Oncology Group.

@nl

type

Item

label

Favorable survival maintained ...... the Children's Oncology Group

@en

Favorable survival maintained ...... the Children's Oncology Group.

@nl

prefLabel

Favorable survival maintained ...... the Children's Oncology Group

@en

Favorable survival maintained ...... the Children's Oncology Group.

@nl

P1476

Favorable survival maintained ...... the Children's Oncology Group

@en

P2093

Alan S Gamis

http://www.w3.org/2001/XMLSchema#string

April D Sorrell

http://www.w3.org/2001/XMLSchema#string

Dorothy Barnard

http://www.w3.org/2001/XMLSchema#string

Franklin O Smith

http://www.w3.org/2001/XMLSchema#string

Jeffrey W Taub

http://www.w3.org/2001/XMLSchema#string

Joanne M Hilden

http://www.w3.org/2001/XMLSchema#string

Lois Hathaway

http://www.w3.org/2001/XMLSchema#string

Robert B Gerbing

http://www.w3.org/2001/XMLSchema#string

Robert J Arceci

http://www.w3.org/2001/XMLSchema#string

Thomas W Loew

http://www.w3.org/2001/XMLSchema#string

P2860

The World Health Organization (WHO) classification of the myeloid neoplasms

Proposals for the classification of the myelodysplastic syndromes

New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues

Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature.

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.

Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group.

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.

Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.

P304

4806-4814

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.27484

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221890154

http://www.w3.org/2001/XMLSchema#string

P698

22392565

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

chemotherapy

P932

3879144

http://www.w3.org/2001/XMLSchema#string

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group

about

P2860

P2860

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932